Leidos (LDOS), Immunovaccine Enter Zika Virus Vaccine Development Collaboration
Tweet Send to a Friend
Immunovaccine Inc. and Leidos (NYSE: LDOS) announced they will collaborate on developing a vaccine against the mosquito-borne Zika virus and ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE